Allogene Therapeutics, Inc. Dividends Per Share
Allogene Therapeutics, Inc. (ALLO) reported Dividends Per Share of $0.00 per share for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:CommonStockDividendsPerShareDeclared · last filed 2026-03-12
- Allogene Therapeutics, Inc. common stock, dividends, per share, declared for the quarter ending 2018-12-31 was $0.00.
- Allogene Therapeutics, Inc. common stock, dividends, per share, declared for fiscal 2025 was $0.00.
- Allogene Therapeutics, Inc. common stock, dividends, per share, declared for fiscal 2024 was $0.00.
- Allogene Therapeutics, Inc. common stock, dividends, per share, declared for fiscal 2023 was $0.00.
- Allogene Therapeutics, Inc. common stock, dividends, per share, declared for fiscal 2022 was $0.00.
| Period end | Common Stock, Dividends, Per Share, Declared 3 month | Common Stock, Dividends, Per Share, Declared 9 month | Common Stock, Dividends, Per Share, Declared 12 month |
|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-12 | ||
| 2024-12-31 | $0.00 10-K · filed 2026-03-12 | ||
| 2023-12-31 | $0.00 10-K · filed 2025-03-13 | ||
| 2022-12-31 | $0.00 10-K/A · filed 2024-03-14 | ||
| 2021-12-31 | $0.00 10-K/A · filed 2024-03-14 | ||
| 2020-12-31 | $0.00 10-K · filed 2022-02-23 | ||
| 2019-12-31 | $0.00 10-K · filed 2021-02-25 | ||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $0.00 10-K · filed 2020-02-27 | |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |